ACE and heart failure: Comparable rates have been observed in the multicentric study ESC-HF Pilot [23] including 5118 patients with heart failure where ACE Inhibitors or ARBs were prescribed in 88.5%, BB in 86.7%, Spironolactone in 43.7% and loop diuretics in 82.8%.